NCT04008914View on ClinicalTrials.gov

Readmission Risk Factors and Heart Failure With Preserved Ejection Fraction

CompletedOBSERVATIONAL

Enrollment

492

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

March 1, 2018

Study Completion Date

January 18, 2019

Conditions

Heart FailurePreserved Ejection Fraction

Interventions

OTHER

retrospective observation

Retrospective review of study patients excluded from the CONNECT- HF trial who were discharged with a diagnosis of HFpEF between August 1, 2017 and March 1, 2018. Readmission rate at 30 and 90 days along with patient demographics and associated comorbidities were analyzed.

Trial Locations (1)

48093

Ascension Macomb-Oakland Hospital, Warren

All Listed Sponsors

lead

Ascension Macomb-Oakland Hospital

OTHER

NCT04008914 - Readmission Risk Factors and Heart Failure With Preserved Ejection Fraction | Biotech Hunter | Biotech Hunter